Infigratinib 0.128 mg/kg ( DrugBank: Infigratinib )

1 disease

ID	Disease name (Link within this page)	Number of trials
276	Achondroplasia	1

276. Achondroplasia

Clinical trials : 51 / Drugs : 34 - (DrugBank : 6) / Drug target genes : 4 - Drug target pathways : 26

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04265651 (ClinicalTrials.gov)	March 10, 2020	29/1/2020	Study of Infigratinib in Children With Achondroplasia	Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study of Infigratinib, an FGFR 1-3-Selective ...	Achondroplasia	Drug: Infigratinib 0.016 mg/kg;Drug: Infigratinib 0.032 mg/kg;Drug: Infigratinib 0.064 mg/kg;Drug: I ...	QED Therapeutics, Inc.	NULL	Recruiting	3 Years	11 Years	All	108	Phase 2	United States;Australia;Canada;France;Spain;United Kingdom

First Previous1Next Last